Prospective, Single-center, Randomized Trial, Intended to Compare Three Revascularization Strategies in Patients With Multi-vessel Coronary Artery Disease
Phase of Trial: Phase III
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms HREVS
- 27 Sep 2017 Status changed from active, no longer recruiting to completed.
- 03 Jun 2017 Planned End Date changed from 1 Dec 2018 to 1 Aug 2020.
- 03 Jun 2017 Status changed from recruiting to active, no longer recruiting.